ClinicalTrials.gov
public full text
Public Domain
A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)
This is a randomized, double-blind, placebo-controlled, dose-ranging Phase 2 study to evaluate the efficacy and safety of CIN-107 as compared to placebo after 12 weeks of treatment in patients with treatment-resistant hypertension (rHTN).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension#424269
- Arterial Hypertension Related to PARP Inhibitors (ArteRIB)#854025
- REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription#1171269
- Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)#861106
- First-In-Human Study Evaluating a Novel Catheter Device in Subjects With Treatment-Resistant Hypertension#208338
Record · ID 1114608
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive